Gene · 5406
Papers3,840
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
221 to 240 of 3,840
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Structural characterization of noni (Morinda citrifolia L.) pectin and its inhibitory activity on pancreatic lipase. | Int J Biol Macromol | 2024 | 39537048 | PubTator, text mining | PubMed |
| In Vitro Purging of Acute Lymphoblastic Leukemia (B-ALL) Cells with the Use of PTL, DMAPT, or PU-H71. | Int J Mol Sci | 2024 | 39519261 | PubTator, text mining | PubMed |
| Antidiabetic, anti-inflammatory, antioxidant, and cytotoxicity potentials of green-synthesized zinc oxide nanoparticles using the aqueous extract of Helichrysum cymosum. | 3 Biotech | 2024 | 39507059 | PubTator, text mining | PubMed |
| Symbiotic probiotic communities with multiple targets successfully combat obesity in high-fat-diet-fed mice. | Gut Microbes | 2024 | 39488738 | PubTator, text mining | PubMed |
| Chemical Profiling, Enzyme Inhibitory Activity and Antioxidant Capacity of South African Herbal Teas: Buddleja saligna, Lippia javanica, L. scaberrima and Phyla dulcis. | Antioxidants (Basel) | 2024 | 39456472 | PubTator, text mining | PubMed |
| Two Triterpenoids, ARM-2 and RA-5, From Protorhus longifolia Exhibit the Potential to Modulate Lipolysis and Lipogenesis in Cultured 3T3-L1 Adipocytes. | J Lipids | 2024 | 39450349 | PubTator, text mining | PubMed |
| Nanostructure Formation in Glycerolipid Films during Enzymatic Hydrolysis: A GISAXS Study. | ACS Appl Mater Interfaces | 2024 | 39448890 | PubTator, text mining | PubMed |
| Preferential inhibition of α-amylase by cinnamaldehyde-based hydrazones: A comparative study. | Int J Biol Macromol | 2024 | 39423966 | PubTator, text mining | PubMed |
| Biological Activities of Soy Protein Hydrolysate Conjugated with Mannose and Allulose. | Foods | 2024 | 39410079 | PubTator, text mining | PubMed |
| RERconverge Expansion: Using Relative Evolutionary Rates to Study Complex Categorical Trait Evolution. | Mol Biol Evol | 2024 | 39404101 | PubTator, text mining | PubMed |
| Bioactivities of Sargassum elegans, Bryopsis myosuroides, Callophyllis variegata seaweeds on diabetes and obesity-related biochemical parameters: A comparative in vitro study. | Fitoterapia | 2024 | 39396650 | PubTator, text mining | PubMed |
| Identification of New Potential Targets for Pancreatic Ductal Adenocarcinoma by Integrated Bioinformatic Analysis. | Anticancer Res | 2024 | 39348994 | PubTator, text mining | PubMed |
| Biodiversity in nutrients and biological activities of 14 highbush blueberry (Vaccinium corymbosum L.) cultivars. | Sci Rep | 2024 | 39333179 | PubTator, text mining | PubMed |
| Two C23-Steroids and a New Isocoumarin Metabolite from Mangrove Sediment-Derived Fungus Penicillium sp. SCSIO 41429. | Mar Drugs | 2024 | 39330274 | PubTator, text mining | PubMed |
| Molecular Docking and Pharmacokinetics Prediction of Piperine and Capsaicin as Human Pancreatic Lipase Inhibitors: An In Silico Study. | Cureus | 2024 | 39328713 | PubTator, text mining | PubMed |
| Identification of pancreatin inhibitors from Thai medicinal Piper plants for antidiabetic and anti-obesity activities using high-performance thin-layer chromatography-bioautographic assay. | J Chromatogr A | 2024 | 39277979 | PubTator, text mining | PubMed |
| Novel Role of the ALPI Gene Associated with Constipation Caused by Complement Component 3 Deficiency. | Int J Mol Sci | 2024 | 39273477 | PubTator, text mining | PubMed |
| Modeling protease-sensitive human pancreatic lipase mutations in the mouse ortholog. | J Biol Chem | 2024 | 39265662 | PubTator, text mining | PubMed |
| Discovery of natural anthraquinones as potent inhibitors against pancreatic lipase: structure-activity relationships and inhibitory mechanism. | J Enzyme Inhib Med Chem | 2024 | 39223707 | PubTator, text mining | PubMed |
| Metabolites profiling of Sapota fruit pulp via a multiplex approach of gas and ultra performance liquid chromatography/mass spectroscopy in relation to its lipase inhibition effect. | PeerJ | 2024 | 39221269 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5406/papers?page=12